Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$61.4M |
| 2 |
Vistra
VST
|
+$60.2M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$44.4M |
| 4 |
ConocoPhillips
COP
|
+$33.8M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$43.5M |
| 2 |
Target
TGT
|
+$30.5M |
| 3 |
Best Buy
BBY
|
+$28.2M |
| 4 |
Canadian Natural Resources
CNQ
|
+$23.9M |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.72% |
| 2 | Financials | 15.54% |
| 3 | Consumer Discretionary | 11.37% |
| 4 | Technology | 11.07% |
| 5 | Energy | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Hartford Financial Services
HIG
$37.6B
| $1.2M | 0.04% |
21,500
+10,400
| +94% | +$549K |
|
402
Watsco Inc
WSO
$12.8B
| $1.19M | 0.04% |
+7,300
| New | +$1.15M |
|
|
PHAS
403
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $1.19M | 0.04% |
90,400
+27,400
| +43% | +$336K |
|
404
iShares Biotechnology ETF
IBB
$10.7B
| $1.18M | 0.04% |
+10,854
| New | +$1.15M |
|
|
CY
405
DELISTED
Cypress Semiconductor
CY
| $1.18M | 0.04% |
53,100
-37,439
| -41% | -$679K |
|
406
F5
FFIV
$21.6B
| $1.18M | 0.04% |
8,100
+5,786
| +250% | +$866K |
|
407
Home Depot
HD
$336B
| $1.17M | 0.04% |
5,647
-19,353
| -77% | -$3.86M |
|
408
Q32 Bio
QTTB
$486M
| $1.17M | 0.04% |
+3,328
| New | +$1.31M |
|
409
Teva Pharmaceuticals
TEVA
$43.2B
| $1.17M | 0.04% |
126,400
+101,400
| +406% | +$1.22M |
|
410
Carlisle Companies
CSL
$14.4B
| $1.17M | 0.04% |
8,296
-22,416
| -73% | -$3.02M |
|
411
Commault Systems
CVLT
$5.46B
| $1.16M | 0.04% |
23,296
+7,545
| +48% | +$401K |
|
412
Willis Towers Watson
WTW
$32.4B
| $1.15M | 0.04% |
6,000
-16,500
| -73% | -$2.99M |
|
413
Norwegian Cruise Line
NCLH
$7.85B
| $1.14M | 0.04% |
21,300
-28,700
| -57% | -$1.6M |
|
414
Ollie's Bargain Outlet
OLLI
$4.6B
| $1.14M | 0.04% |
13,102
-3,698
| -22% | -$349K |
|
415
Jack Henry & Associates
JKHY
$12.1B
| $1.14M | 0.04% |
+8,482
| New | +$1.17M |
|
|
ALXN
416
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.14M | 0.04% |
8,678
+6,703
| +339% | +$864K |
|
417
Tapestry
TPR
$26.4B
| $1.13M | 0.04% |
+35,700
| New | +$1.11M |
|
418
Twilio
TWLO
$34.2B
| $1.13M | 0.04% |
8,300
-2,100
| -20% | -$280K |
|
419
Insperity
NSP
$2B
| $1.12M | 0.04% |
9,144
-756
| -8% | -$91.1K |
|
420
Elanco Animal Health
ELAN
$12B
| $1.11M | 0.04% |
32,900
+30,000
| +1,034% | +$974K |
|
421
Progressive
PGR
$129B
| $1.11M | 0.04% |
+13,916
| New | +$1.08M |
|
|
VG
422
DELISTED
Vonage Holdings Corporation
VG
| $1.11M | 0.04% |
98,000
-346,800
| -78% | -$3.75M |
|
423
Johnson Controls International
JCI
$86.1B
| $1.1M | 0.04% |
26,621
+1,650
| +7% | +$63.5K |
|
424
Assurant
AIZ
$14.1B
| $1.1M | 0.04% |
10,300
-45,100
| -81% | -$4.46M |
|
425
Arthur J. Gallagher & Co
AJG
$69B
| $1.1M | 0.04% |
12,500
-20,287
| -62% | -$1.69M |
|
Similar funds
Steve Schonfeld's Q2 2019 Portfolio in Review
As of Q2 2019, Steve Schonfeld held 1,400 positions worth $2.83B, down 1.8% from $2.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $96.1M in Q2 2019, closing 442 positions and reducing 316 holdings. Its most notable exit was Conagra Brands, an estimated $43.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Equitrans Midstream Corporation Common Stock worth $42.1M.
- Steve Schonfeld's largest Q2 2019 buy was Equitrans Midstream Corporation Common Stock: 2,136,064 shares worth $42.1M.
- Steve Schonfeld added most to NRG Energy in Q2 2019, an estimated $61.4M increase.
- Steve Schonfeld's biggest Q2 2019 reduction was Target, cutting an estimated $30.5M.
- Steve Schonfeld fully exited Conagra Brands in Q2 2019, selling an estimated $43.5M.
- Steve Schonfeld's ten largest holdings make up 16% of its $2.83B portfolio in Q2 2019.
- Steve Schonfeld opened 374 new positions and closed 442 in Q2 2019.
- Steve Schonfeld's portfolio value fell 1.8% quarter-over-quarter to $2.83B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.